dc.contributor.author | Díaz Calvillo, Pablo | |
dc.contributor.author | Muñoz Barba, Daniel | |
dc.contributor.author | Ureña Paniego, Clara Amanda | |
dc.contributor.author | Maul, Lara Valeska | |
dc.contributor.author | Cerminara, Sara | |
dc.contributor.author | Kostner, Lisa | |
dc.contributor.author | Martínez López, Antonio | |
dc.contributor.author | Arias Santiago, Salvador Antonio | |
dc.date.accessioned | 2024-06-03T09:56:50Z | |
dc.date.available | 2024-06-03T09:56:50Z | |
dc.date.issued | 2024-03-14 | |
dc.identifier.citation | Díaz-Calvillo P, Muñoz-Barba D, Ureña-Paniego C, Maul LV, Cerminara S, Kostner L, Martínez López A, Arias-Santiago S. Effects of COVID-19 Pandemic on the Diagnosis of Melanoma and Keratinocyte Carcinomas: a Systematic Review and Meta-analysis. Acta Derm Venereol. 2024 Mar 14;104:adv19460. doi: 10.2340/actadv.v104.19460 | es_ES |
dc.identifier.uri | https://hdl.handle.net/10481/92255 | |
dc.description.abstract | Since December 2019, the COVID-19 pandemic has
profoundly affected healthcare. The real effects of the
COVID-19 pandemic on skin cancer are still unclear,
more than 3 years later. This study aims to summarise
the pandemic’s impact on skin cancer diagnosis and
outcome. A systematic review and meta-analysis was
conducted, selecting studies comparing skin cancer
diagnosis
and prognosis post-pandemic with pre-pandemic
data. A total of 27 papers were reviewed including
102,263 melanomas and 271,483 keratinocyte
carcinomas. During the initial pandemic months (January–
July 2020), melanoma surgeries dropped by 29.7%
and keratinocyte carcinomas surgeries by 50.8%. Early
pandemic tumours exhibited greater thickness and
stage. In a long-term period beyond the initial months,
melanoma surgeries decreased by 9.3%, keratinocyte
carcinomas by 16.6%. No significant differences were
observed in the Breslow thickness of melanomas after
the start of the pandemic (mean difference 0.06, 95%
confidence interval –0.46, 0.58). Melanomas operated on
post-pandemic onset had an increased risk of ulceration
(odds ratio 1.35, 95% confidence interval 1.22–1.50).
Keratinocyte carcinomas showed increased thickness
and worsened stage post-pandemic. However,
studies
included were mostly retrospective and cross-sectional,
reporting diverse data. This review indicates that the
pandemic likely caused delays in skin cancer diagnosis
and treatment, potentially impacting patient outcomes. | es_ES |
dc.language.iso | eng | es_ES |
dc.publisher | MJS Publishing | es_ES |
dc.rights | Atribución-NoComercial 4.0 Internacional | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc/4.0/ | * |
dc.subject | Melanoma | es_ES |
dc.subject | Squamous cell carcinoma | es_ES |
dc.subject | Basal cell carcinoma | es_ES |
dc.title | Effects of COVID-19 Pandemic on the Diagnosis of Melanoma and Keratinocyte Carcinomas: a Systematic Review and Meta-analysis | es_ES |
dc.type | journal article | es_ES |
dc.rights.accessRights | open access | es_ES |
dc.identifier.doi | 10.2340/actadv.v104.19460 | |
dc.type.hasVersion | VoR | es_ES |